Findings published by Northwestern Medicine scientists in Molecular Cell suggest that the upregulation of protein WDR5 may be crucial in prostate cancer development.
Kamonwan Pear Fish, a PhD/MPH student, uses mouse models to study how a viral protein from the Epstein Barr Virus can disrupt cell function and accelerate tumor growth.
Shelby Rubin, PA ’15, has already accomplished something most people haven’t – the founding and running of a nonprofit organization called Camp Kesem, a free summer camp for children ages 6 to 16 whose lives have been affected by a parent’s cancer.
Despite advances in neurosurgical techniques and radiation oncology, malignant brain tumors are the fourth most common cancer death in the United States. A recent publication by Northwestern Medicine scientists has revealed a potentially novel treatment option.
Findings indicate that regular vitamin D screenings may be beneficial, especially for African- and European-American men.
Scientists from five institutions, including Northwestern, discovered a cancer-specific biomarker found in all stages of breast, prostate and pancreatic cancers.
Marcus Peter, PhD, professor in Medicine-Hematology/Oncology, has discovered how the removal of a known “tumor suppressor” causes cancer cells to kill themselves.
Northwestern Medicine scientists have developed a new prognostic tool for clinicians treating patients with large B-cell lymphoma. The predictive scale enhances the widely used International Prognostic Index.
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University has named Deputy Director Leonidas Platanias, MD, PhD, professor of Medicine-Hematology/Oncology, interim director, effective immediately.